Clearmind Medicine Inc. · NASDAQ:CMND

Clearmind Medicine Inc. financial statements

Clearmind Medicine Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Research and development2.06M1.38M1.54M3.08M473.7K
Selling, general and administrative4.36M4.76M3.17M2.22M
Depreciation and amortization38.4K1.06K11.2K7.57K1.88K
Interest expense3.86K5.39K
Income before tax-3.79M-4.88M-8.60M-6.87M-2.73M
Income tax70.4K378.0K17.4K29.9K
Net income-3.86M-5.25M-8.62M-6.89M-2.73M
Earnings per share, basic-30.35-67.80-1,703.04-159.11-88.16
Earnings per share, diluted-30.35-67.80-1,703.04-159.11-88.16

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents3.92M6.57M5.43M128.8K3.37M
Short-term investments1.66M289.4K86.1K
Receivables50.9K
Current assets5.95M7.09M5.79M434.7K
Property, plant and equipment1.73K12.9K
Total assets6.08M7.26M5.95M826.4K
Accounts payable526.1K617.0K
Current liabilities4.89M4.13M4.97M
Total liabilities4.89M4.15M4.97M1.93M
Shareholders' equity1.19M3.11M983.5K-1.11M3.52M
Shares outstanding44.0K1.25M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations-4.73M-4.86M-6.30M-3.72M-2.08M
Capital spending-5.56K-17.0K
Free cash flow-3.73M-2.09M
Cash from investing-542.0K-238.1K-26.2K-5.56K-184.0K
Cash from financing2.62M6.25M11.7M511.7K5.39M
Change in cash-2.65M1.15M5.30M-3.24M3.13M